Medicare Enrolled

Dr. Ganapathy Krishnan, M.D.

Hematology & Oncology · Fife, WA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
3700 PACIFIC HWY E STE 100, Fife, WA 98424
2533826300
Registered in NPPES since 2007
NPI: 1063537645 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Krishnan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Krishnan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Krishnan

Dr. Ganapathy Krishnan is a hematology & oncology specialist in Fife, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Krishnan performed 759 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Krishnan received a total of $6,722 from 54 pharmaceutical and/or device companies across 231 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Krishnan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 41% volume in WA $6,722 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
759
Medicare services
Top 41% in WA for hematology & oncology
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
475 $69 $115
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
152 $42 $80
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
108 $106 $159
New patient office visit, complex (60-74 min) 12 $140 $196
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $102 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,722
Total received (2018-2024)
Avg $960/year across 7 years
Top 25% in WA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
231
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,428
2023
$1,556
2022
$28
2021
$229
2020
$16
2019
$62
2018
$403

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$625
AstraZeneca Pharmaceuticals LP
$559
Janssen Biotech, Inc.
$306
E.R. Squibb & Sons, L.L.C.
$195
ABBVIE INC.
$191
SOBI, INC
$182
Daiichi Sankyo Inc.
$178
PFIZER INC.
$177
Celgene Corporation
$160
BeiGene USA, Inc.
$146
Incyte Corporation
$128
TerSera Therapeutics LLC
$126
Genentech USA, Inc.
$103
Astellas Pharma US Inc
$101
ARRAY BIOPHARMA INC
$98
Regeneron Healthcare Solutions, Inc.
$93
Merck Sharp & Dohme LLC
$87
Takeda Pharmaceuticals U.S.A., Inc.
$84
Bayer Healthcare Pharmaceuticals Inc.
$84
Gilead Sciences, Inc.
$76
Eisai Inc.
$65
ADC Therapeutics America, Inc.
$57
GlaxoSmithKline, LLC.
$55
GENZYME CORPORATION
$50
Stemline Therapeutics Inc.
$49
Exelixis Inc.
$39
Tempus AI, Inc
$37
Acrotech Biopharma Inc.
$35
Mirati Therapeutics, Inc.
$34
SpringWorks Therapeutics, Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$29
Dendreon Pharmaceuticals LLC
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Deciphera Pharmaceuticals Inc.
$23
Helsinn Therapeutics (U.S.), Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
ACCORD HEALTHCARE, INC.
$18
Adaptive Biotechnologies Corporation
$17
Lilly USA, LLC
$16
Genmab U.S., Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Echosens North America, Inc.
$13
Top 3 companies account for 33.7% of 2024 payments
All-time payments by company (2018-2024) ›
TAIHO ONCOLOGY, INC.
$1,350
Novartis Pharmaceuticals Corporation
$706
AstraZeneca Pharmaceuticals LP
$581
Janssen Biotech, Inc.
$375
E.R. Squibb & Sons, L.L.C.
$249
ABBVIE INC.
$218
Incyte Corporation
$200
PFIZER INC.
$199
Celgene Corporation
$192
SOBI, INC
$182
Daiichi Sankyo Inc.
$178
Takeda Pharmaceuticals U.S.A., Inc.
$166
BeiGene USA, Inc.
$146
Genentech USA, Inc.
$135
Eisai Inc.
$130
TerSera Therapeutics LLC
$126
Lilly USA, LLC
$116
Astellas Pharma US Inc
$114
Regeneron Healthcare Solutions, Inc.
$108
Merck Sharp & Dohme LLC
$100
ARRAY BIOPHARMA INC
$98
Bayer Healthcare Pharmaceuticals Inc.
$84
Exelixis Inc.
$81
Gilead Sciences, Inc.
$76
GENZYME CORPORATION
$63
ADC Therapeutics America, Inc.
$57
GlaxoSmithKline, LLC.
$55
Stemline Therapeutics Inc.
$49
Merck Sharp & Dohme Corporation
$39
Tempus AI, Inc
$37
Acrotech Biopharma Inc.
$35
Mirati Therapeutics, Inc.
$34
JAZZ PHARMACEUTICALS INC.
$31
SpringWorks Therapeutics, Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$29
AbbVie, Inc.
$26
AMAG Pharmaceuticals, Inc.
$25
Dendreon Pharmaceuticals LLC
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$24
Deciphera Pharmaceuticals Inc.
$23
Puma Biotechnology, Inc.
$22
Helsinn Therapeutics (U.S.), Inc.
$22
Aveo Pharmaceuticals, Inc.
$22
Myriad Genetic Laboratories, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
ACCORD HEALTHCARE, INC.
$18
Adaptive Biotechnologies Corporation
$17
Genmab U.S., Inc.
$14
Alnylam Pharmaceuticals Inc.
$14
Echosens North America, Inc.
$13
Taiho Oncology, Inc.
$13
Seagen Inc.
$13
Pharmacyclics LLC, An AbbVie Company
$12
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
ABECMA · AKYNZEO · ALTUVIIIO · ALUNBRIG · AUGTYRO · Abraxane · Adempas · Aliqopa · Avastin · BELEODAQ · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FERAHEME · FOTIVDA · FRUZAQLA · Fabhalta · FibroScan · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LORBRENA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MYRISK · NINLARO · Nerlynx · OGSIVEO · ONGLYZA · ONPATTRO · OPDIVO · OPDUALAG · Orserdu · PADCEV · PROMACTA · PROVENGE · PYLARIFY · Padcev · Phesgo · QINLOCK · Quzyttir · REBLOZYL · RYBREVANT · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SPRYCEL · TAGRISSO · TASIGNA · TECVAYLI · VENCLEXTA · VERZENIO · VONJO · Venclexta · WELIREG · XALKORI · Xospata · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Fife?
Compare hematology & oncology specialists in the Fife area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
40
County median income
$96,632
Nearest hospital to ZIP centroid (approximate)
MULTICARE GOOD SAMARITAN HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Krishnan is a clinical cardiology specialist, with moderate Medicare volume, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Krishnan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Krishnan performed 475 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Krishnan receive payments from pharmaceutical companies?
Yes. Dr. Krishnan received a total of $6,722 from 54 companies across 231 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Krishnan's costs compare to other hematology & oncology specialists in Fife?
Dr. Krishnan's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Krishnan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →